Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors
Throughout its known history, the gram-negative bacterium Chlamydia pneumoniae has remained a challenging target for antibacterial chemotherapy and drug discovery. Owing to its well-known propensity for persistence and recent reports on antimicrobial resistence within closely related species, new ap...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2016-11-01
|
| Seri Bilgileri: | Microorganisms |
| Konular: | |
| Online Erişim: | http://www.mdpi.com/2076-2607/4/4/43 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|